Unlock Self-healing Power with Daily Insights and Advanced Science
Searching…
Search is temporarily unavailable. Please try again.
Blog search results updated.
No articles found. Try a different keyword.
World Bipolar Day: How Vagus Nerve Stimulation May Support Better Mental Health
March 30 is World Bipolar Day — and a reminder to look beyond the label of "mood swings." In this article, ZenoWell explores what HRV research, neuroimmune science, and vagus nerve pathways reveal about bipolar disorder, and asks a forward-looking question: could taVNS become a meaningful tool for supporting emotional regulation and autonomic balance in this population? Read more →
ZenoWell vagus nerve stimulation for women’s wellness
Throughout life, women are constantly dealing with hormonal changes. Monthly menstrual cycles, postpartum, and the long transition around menopause all leave a mark on both body and mind. Poor sleep, high stress, anxiety, mood swings, fatigue, and of course, the all‑too‑familiar menstrual pain—these are not just “in your head”.
These experiences are not only about hormones. Increasingly, resear...
Rebalancing during menopause: How ZenoWell ear-based vagus nerve stimulation (taVNS) can help
Menopause is not a breakdown—it's a biological transition. Yet for many women, this transition comes with a range of unexpected and disruptive symptoms: sleepless nights, emotional instability, chronic fatigue, migraines, and a general feeling of being “off.”
What if there was a way to gently support your body and nervous system through this shift—without drugs or invasive procedures?
Emerging ...
Science update: taVNS matches antidepressants in treating depression — with fewer side effects
Two newly published scientific reviews provide compelling evidence for the use of transcutaneous auricular vagus nerve stimulation (taVNS) as a safe, effective intervention for depression and anxiety-related conditions.
As depression continues to impact hundreds of millions worldwide, the need for non-pharmacological, accessible, and well-tolerated treatment options has become increasingly urge...
Potential of ZenoWell taVNS supporting HIV/AIDS patients' depression
Depressive symptoms are not uncommon among HIV/AIDS patients, but have been neglected for a long time. Studies show that about 20% -30% of HIV-infected individuals have obvious depressive symptoms . These patients often face multiple pressures such as chronic infection, drug side effects, immune dysfunction, and social stigma, which makes traditional antidepressant treatment face challenges in...